This information is intended only for healthcare professionals resident in the Great Britain

Prescribing Information (PI) for ▼Zirabev (bevacizumab) Great Britain (GB) and Northern Ireland (NI)​​​​​

Pfizer Ltd. accepts no responsibility for the content or services of the linked site other than the information relating to Pfizer medicines which it has provided or reviewed

Great Britain

  • Zirabev (bevacizumab) 25mg/ml concentrate for solution for infusion (100mg/4ml) - PI for GB
  • Zirabev (bevacizumab) 25mg/ml concentrate for solution for infusion (400mg/16ml) - PI for GB

Northern Ireland

  • Zirabev (bevacizumab) 25mg/ml concentrate for solution for infusion - PI for NI

Zirabev (bevacizumab) 25mg/ml concentrate for solution for infusion (100mg/4ml) - PI for GB

Zirabev (bevacizumab) 25mg/ml concentrate for solution for infusion (400mg/16ml) - PI for GB

Zirabev (bevacizumab) 25mg/ml concentrate for solution for infusion - PI for NI

PP-ZIR-GBR-0031 March 2024